According to Hims & Hers Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.80097. At the end of 2023 the company had a P/S ratio of 2.16.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.16 | -14.38% |
2022 | 2.53 | -48.56% |
2021 | 4.91 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 42.7 | 1,024.26% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | 357.91% | ๐ฌ๐ง UK |
Novavax NVAX | 0.9647 | -74.62% | ๐บ๐ธ USA |
Novocure
NVCR | 3.29 | -13.54% | Jersey |